-
Cosmederm Bioscience claims superior anti-itch efficacy for TriCalm
SAN DIEGO — Cosmederm Bioscience last week announced that a study recently published in the journal Acta Dermato-Venereologica has established its TriCalm anti-itch product has greater anti-itch efficacy as compared with products containing hydrocortisone or diphenhydramine.
-
Pharmaceutical balance tipping to specialty side
The new world of targeted, specialized medicines — many of them bioengineered and many of them aimed at smaller and smaller segments of the population — isn’t just on its way. It’s here. And it’s going to radically change the practice of pharmacy.
Here’s an eye-opener: Specialty drugs will likely account for 50% of all drug costs by 2018, up from 28.7% of total prescription drug costs in 2012.